Source-grounded facts extracted from CRYO CELL INTERNATIONAL INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
CRYO CELL INTERNATIONAL INC received a nyse_american extension granted notice regarding other.
“May 6, 2026, Cryo-Cell International, Inc. (the "Company”) received a written notice from NYSE Regulation stating that it had accepted the Company’s plan to regain compliance with the continued listing standards of the N”
CRYO CELL INTERNATIONAL INC received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)).
“March 9, 2026, Cryo-Cell International, Inc. (“Cryo-Cell”) received a written notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating that the Company is not in compliance with the continued listing standards set forth in Section 1003 (a) of the NYSE American Company Guide. The Notice has no immediate effect on the listing or trading of the Company’s common stock, which will continue to trade on the NYSE American under the symbol “CCEL” while the Company pursues a plan to regain compliance. In accordance with NYSE American procedures, the Company intends to submit a plan of”
CRYO CELL INTERNATIONAL INC amended credit facility of $8,000,000 with Susser Bank at Base Rate plus 4.25% for Term Loans, Base Rate plus 3.75% for Revolving Credit L maturing October 18, 2027 for RCF Note; July 29, 2032 for Term Note.
“Date to October 18, 2027 and extended the Maturity Date of the Term Note to July 29, 2032. Revolving Credit Limit. The Amendment revised the revolving credit commitment to $8,000,000. Applicable Margin . The Amendment revised the Applicable Margin per annum as set forth below: Base Rate with respect to Term Loans Base Rate with respect to Revolving Credit”
CRYO CELL INTERNATIONAL INC shareholders approved Authorization to vote the proxies upon other business properly coming before the Meeting or any adjournments or postponements thereof at the 2023-10-10 meeting.
“4. Authorization to vote the proxies upon other business properly coming before the Meeting or any adjournments or postponements thereof. For Against Abstain 3,056,073 409,735 42,916”
CRYO CELL INTERNATIONAL INC shareholders approved Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers at the 2023-10-10 meeting.
“3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. For Against Abstain 3,038,636 365,541 104,547”
CRYO CELL INTERNATIONAL INC shareholders approved Ratification of appointment of WIPFLI LLC as independent registered public accounting firm at the 2023-10-10 meeting.
“2. The ratification of appointment of WIPFLI LLC as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2023. For Against Abstain 6,328,614 159,161 4,717”
CRYO CELL INTERNATIONAL INC shareholders approved Election of four directors at the 2023-10-10 meeting.
“1. To consider the election of four individuals to the Company's Board of Directors. David Portnoy For 3,100,610 Withhold 408,114 Harold Berger For 3,119,399 Withhold 389,325 Mark Portnoy For 3,100,159 Withhold 408,565 Daniel Mizrahi For 3,174,329 Withhold 334,395”
CRYO CELL INTERNATIONAL INC entered into Clinical Study and Research Agreement with Duke valued at 14 equal monthly payments commencing in April 2023 and a final payment (effective 2023-03-03).
“As part of the Second Amendment, on March 3, 2023, the Company entered into the Clinical Study and Research Agreement (the “Research Agreement”) with Duke to provide funding to complete the Duke IMPACT Study”
CRYO CELL INTERNATIONAL INC amended Second Amendment to the License Agreement with Duke (effective 2023-02-17).
“On February 17, 2023, Cryo-Cell International, Inc. ("Company") entered into a Second Amendment to the License Agreement (the “Second Amendment”) with Duke”
Brian Sheehy resigned as director at CRYO CELL INTERNATIONAL INC.
“On December 13, 2021, Brian Sheehy resigned as a director of Cryo-Cell International, Inc.”
Daniel Mizrahi was appointed as Director at CRYO CELL INTERNATIONAL INC.
“On September 20, 2021 the Board of the Company appointed Mark Portnoy, the Company’s Co-CEO, and Daniel Mizrahi to the Board as directors.”
Mark Portnoy was appointed as Director at CRYO CELL INTERNATIONAL INC.
“On September 20, 2021 the Board of the Company appointed Mark Portnoy, the Company’s Co-CEO, and Daniel Mizrahi to the Board as directors.”
Jonathan Wheeler resigned as Director at CRYO CELL INTERNATIONAL INC.
“Effective September 17, 2021 and September 20, 2021, George Gaines and Jonathan Wheeler, MD (respectively) resigned as directors of Cryo-Cell International, Inc.”
George Gaines resigned as Director at CRYO CELL INTERNATIONAL INC.
“Effective September 17, 2021 and September 20, 2021, George Gaines and Jonathan Wheeler, MD (respectively) resigned as directors of Cryo-Cell International, Inc.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.